Clinical trials
Terminated Phase 1/2 trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Sanofi | 4 |
| Bristol-Myers Squibb | 2 |
| Hoffmann-La Roche | 2 |
| National Health Research Institutes, Taiwan | 2 |
| Pfizer | 2 |
| PharmaEngine | 2 |
| Taiwan Liposome Company | 2 |
| ASLAN Pharmaceuticals | 1 |
| Adherex Technologies, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 11 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Neoplasm Metastasis | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Melanoma | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.